These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 11817007

  • 61. [The effect of artificial tears on corneal surface regularity in dry eye].
    Liu Z, Xie Y, Zhang M, Pflugfelder SC.
    Zhonghua Yan Ke Za Zhi; 2000 Mar; 36(2):131-4. PubMed ID: 11853602
    [Abstract] [Full Text] [Related]

  • 62. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D, Bloch-Michel E, Verin P, Sebastiani A, Tazartes M, Helleboid L, Di Giovanni A, Lecorvec M.
    Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Mitomycin-C and vernal conjunctivitis.
    MacLeod JD.
    Ophthalmology; 2000 Dec; 107(12):2127. PubMed ID: 11097580
    [No Abstract] [Full Text] [Related]

  • 69. Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease.
    Murphy PT, Sivakumaran M, Fahy G, Hutchinson RM.
    Bone Marrow Transplant; 1996 Sep; 18(3):641-2. PubMed ID: 8879631
    [Abstract] [Full Text] [Related]

  • 70. Ocular surface damage by ophthalmic compounds.
    Mantelli F, Tranchina L, Lambiase A, Bonini S.
    Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):464-70. PubMed ID: 21822131
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Antiallergic activity of topical lodoxamide on in vivo and in vitro models.
    Ciprandi G, Buscaglia S, Catrullo A, Paolieri F, Riccio AM, Fiorino N, Canonica GW.
    Allergy; 1996 Dec; 51(12):946-51. PubMed ID: 9020426
    [Abstract] [Full Text] [Related]

  • 73. Pharmacological mechanism of topical lodoxamide treatment in vernal keratoconjunctivitis: a flow-cytometric study.
    Avunduk AM, Avunduk MC, Dayanir V, Tekelioğlu Y, Dayioğlu YS.
    Ophthalmic Res; 1998 Dec; 30(1):37-43. PubMed ID: 9483586
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Lodoxamide for vernal keratoconjunctivitis.
    Med Lett Drugs Ther; 1994 Mar 18; 36(918):26. PubMed ID: 8121328
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.